Protein involved in disease progression reveals insights for intervention
Wednesday, September 7, 2011 - 10:00
in Health & Medicine
A team of scientists from the University of Colorado and EMSL has characterized the biology of CD147, a type I transmembrane protein involved in the progression of inflammatory diseases, infections, and cancerespecially the cancer that develops in the cells of the retina, retinoblastoma. Using several methods including EMSLs high-field nuclear magnetic resonance (NMR), the researchers also identified how the proteins activity can be disrupted to reveal targets for therapeutic intervention.